Literature DB >> 33707053

Epithelial cell dysfunction in coeliac disease.

Celia Escudero-Hernández1.   

Abstract

The intestinal epithelium limits host-luminal interactions and maintains gut homeostasis. Breakdown of the epithelial barrier and villous atrophy are hallmarks of coeliac disease. Besides the well characterized immune-mediated epithelial damage induced in coeliac mucosa, constitutional changes and early gluten direct effects disturb intestinal epithelial cells. The subsequent modifications in key epithelial signaling pathways leads to outnumbered immature epithelial cells that, in turn, facilitate epithelial dysfunction, promote crypt hyperplasia, and increase intestinal permeability. Consequently, underlying immune cells have a greater access to gluten, which boosts the proinflammatory immune response against gluten and positively feedback the epithelial damage loop. Gluten-free diet is an indispensable treatment for coeliac disease patients, but additional therapies are under development, including those that reinforce intestinal epithelial healing. In this chapter, we provide an overview of intestinal epithelial cell disturbances that develop during gluten intake in coeliac disease mucosa.
© 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetics; Gluten-free diet; Gut barrier; Intestinal epithelial cell; Intestinal permeability; Intestinal stem cell; Methylation; Microbiota; Organoid; Wnt signaling

Mesh:

Substances:

Year:  2020        PMID: 33707053     DOI: 10.1016/bs.ircmb.2020.09.007

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  1 in total

1.  Eugenol alleviates transmissible gastroenteritis virus-induced intestinal epithelial injury by regulating NF-κB signaling pathway.

Authors:  Kang Wang; Daiwen Chen; Bing Yu; Jun He; Xiangbing Mao; Zhiqing Huang; Hui Yan; Aimin Wu; Yuheng Luo; Ping Zheng; Jie Yu; Junqiu Luo
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.